VERITY ASSET MANAGEMENT, INC. Halozyme Therapeutics, Inc. Transaction History

VERITY ASSET MANAGEMENT, INC. portfolio value:

$1.26M
portfolio value

VERITY ASSET MANAGEMENT, INC. quarter portfolio value change:

-0.85%
quarter

Halozyme Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +1.89% 592 shares 11.85K $39.54 31.88K
Q1 2022 share Decrease -12.57% -4.50K shares -191K $39.88 31.29K
Q4 2021 share Increase +18.37% 5.55K shares 209K $40.32 35.79K
Q3 2021 share Increase +36.62% 8.10K shares 225K $40.68 30.24K
Q2 2021 share Increase +14.63% 2.82K shares 200K $45.41 22.13K
Q1 2021 share Increase +3.96% 735 shares 12K $41.69 19.31K
Q4 2020 share Decrease -5.92% -1.16K shares 274K $42.71 18.57K
Q3 2020 share Decrease -10.69% -2.36K shares -74K $26.28 19.74K
Q2 2020 share Decrease -7.32% -1.74K shares 164K $26.81 22.10K
Q1 2020 share Decrease -19.79% -5.88K shares -98K $17.99 23.85K
Q4 2019 share Decrease -3.67% -1.13K shares 48K $17.73 29.73K
Q3 2019 share Decrease -1.46% -458 shares -59K $15.51 30.87K
Q2 2019 share Increase +45.25% 9.76K shares 191K $17.18 31.32K
Q1 2019 share Increase +6.18% 1.25K shares 50K $16.1 21.56K
Q4 2018 share Increase 0.00% 20.31K shares 297K $14.63 20.31K